Endometrial Uterine Cancer—20-Year Comparative Mortality and Survival Analysis by Age, Race/Ethnicity, Stage, Grade, Disease Duration, Selected ICD-O-3 Histologic Oncophenotypes, and Cohort Entry Time Period: A Systematic Analysis of 155,218 Cases for Diagnosis Years 1975-2023
This study encompasses a review of 155,218 cases from 1975 to 2023 using the National Cancer Institute’s Surveillance, Epidemiology, and End Results 8 Registry. Endometrial cancer is the most common gynecologic malignancy in the United States and accounts for 7% of all cancers in women. In 2026, the estimated number of...